Monthly Archives: January 2010

Sibutramine withdrawn (Reductil)

Sibutramine has been withdrawn. The European-wide review of the anti-obesity drug sibutramine (Reductil) has concluded and an opinion reached recommending the suspension of the licence for the medicine across Europe. Evidence suggests that there is an increased risk of non-fatal … Continue reading

Posted in EMEA, MHRA | Comments Off

Drug Safety Update January 2010

The MHRA have published a new Drug Safety Update (January 2010 [PDF]), which includes information on phenytoin: HLA-B*1502 may be associated with an increased risk of developing SJS in individuals of Thai or Han Chinese ethnic origin when treated with … Continue reading

Posted in MHRA | Comments Off